Funder: National Institutes of Health
Due Dates: May 7, 2025 | September 7, 2025 | January 7, 2026 | May 7, 2026
Funding Amounts: Up to $450,000 in direct costs over 3 years; no more than $225,000 in direct costs in any single year.
Summary: Supports development, pilot-testing, and feasibility studies of novel interventions to improve HIV prevention, treatment, and program implementation for people who use substances, requiring a clinical trial.
Key Information: Clinical trial required; end-user/community engagement in research design is mandatory.